-
Andexanet alfa, sold
under the
brand name
Andexxa among others, is an
antidote for the
medications rivaroxaban and apixaban, when
reversal of anticoagulation...
- the U.S. Food and Drug
Administration in May 2018,
under the
trade name
AndexXa.
Rivaroxaban inhibits both free and
bound Factor Xa in the prothrombinase...
- 2020. "
Andexxa-
andexanet alfa injection, powder, lyophilized, for solution". DailyMed. 8
January 2019.
Retrieved 23
December 2019. "
Andexxa (coagulation...
- (Kanuma), used to
treat lysosomal acid
lipase deficiency, and
andexanet alfa (
Andexxa), used to stop life
threatening or
uncontrollable bleeding in
people who...
- case in the
proposed settlement amount of $17.5 million.
Andexanet alfa (
Andexxa), a
coagulation factor Xa (recombinant), inactivated-zhzo, the
first and...
- 2019.
Ovanesov M (3
August 2017). "Summary
basis for
regulatory action -
ANDEXXA". Food and Drug Administration.
Retrieved 6
November 2019. "Ondexxya"....
-
Portola Pharmaceuticals, Inc. "U.S. FDA
Approves Portola Pharmaceuticals'
Andexxa,
First and Only
Antidote for the
Reversal of
Factor Xa Inhibitors". GlobeNewswire...
-
clinical trials.
These are
letaxaban from
Takeda and
eribaxaban from Pfizer.
Andexxa (Andexanet alfa) from
Portola Pharmaceuticals is a
recombinant protein...
